To further determine whether MALAT1 increases EZH2 recruitment and H3K27me3 levels at EZH2 target loci, we performed a ChIP assay using anti-EZH2 and anti-H3K27me3 antibodies in MCL cells treated with si-MALAT1 or si-NC. The gene discussed is EZH2; the disease is mantle cell lymphoma.